- Home
- OCS vs BLND Comparison
OCS vs BLND Comparison
Compare OCS & BLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCS
- BLND
- Stock Information
- Founded
- OCS 2003
- BLND 2012
- Country
- OCS Switzerland
- BLND United States
- Employees
- OCS N/A
- BLND N/A
- Industry
- OCS Biotechnology: Pharmaceutical Preparations
- BLND EDP Services
- Sector
- OCS Health Care
- BLND Technology
- Exchange
- OCS Nasdaq
- BLND Nasdaq
- Market Cap
- OCS 904.3M
- BLND 800.3M
- IPO Year
- OCS N/A
- BLND 2021
- Fundamental
- Price
- OCS $19.03
- BLND $3.35
- Analyst Decision
- OCS Strong Buy
- BLND Buy
- Analyst Count
- OCS 4
- BLND 8
- Target Price
- OCS $29.50
- BLND $4.66
- AVG Volume (30 Days)
- OCS 42.6K
- BLND 3.6M
- Earning Date
- OCS 03-11-2025
- BLND 05-07-2025
- Dividend Yield
- OCS N/A
- BLND N/A
- EPS Growth
- OCS N/A
- BLND N/A
- EPS
- OCS N/A
- BLND N/A
- Revenue
- OCS $757,024.00
- BLND $162,019,000.00
- Revenue This Year
- OCS $927.26
- BLND $15.24
- Revenue Next Year
- OCS $292.79
- BLND $23.01
- P/E Ratio
- OCS N/A
- BLND N/A
- Revenue Growth
- OCS N/A
- BLND 3.30
- 52 Week Low
- OCS $10.55
- BLND $2.08
- 52 Week High
- OCS $23.08
- BLND $5.53
- Technical
- Relative Strength Index (RSI)
- OCS 42.80
- BLND 43.35
- Support Level
- OCS $18.30
- BLND $3.39
- Resistance Level
- OCS $20.00
- BLND $3.87
- Average True Range (ATR)
- OCS 0.71
- BLND 0.22
- MACD
- OCS 0.09
- BLND 0.01
- Stochastic Oscillator
- OCS 61.35
- BLND 4.55
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
About BLND Blend Labs Inc.
Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.